Loading...
The effects of GCSF primary prophylaxis on survival outcomes and toxicity in patients with advanced non-small cell lung cancer on first-line chemoimmunotherapy: a sub-analysis of the Spinnaker study
Anpalakhan, S. Huddar, Prerana Behrouzi, Roya Signori, A. Cave, J. Comins, C. Cortellini, A. Addeo, A. Escriu, C. McKenzie, H.
Anpalakhan, S.
Huddar, Prerana
Behrouzi, Roya
Signori, A.
Cave, J.
Comins, C.
Cortellini, A.
Addeo, A.
Escriu, C.
McKenzie, H.
Citations
Altmetric:
Abstract
Description
Date
2023
Publisher
Collections
Files
Keywords
Type
Article
Citation
Anpalakhan S, Huddar P, Behrouzi R, Signori A, Cave J, Comins C, et al. The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker Study. International journal of molecular sciences. 2023 Jan 16;24(2). PubMed PMID: 36675262. Pubmed Central PMCID: PMC9867035. Epub 2023/01/22. eng.